Juan Jacobo González Guijarro-rekin lankidetzan egindako argitalpenak (2)

2020

  1. Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy

    Ocular Immunology and Inflammation, pp. 1-8

  2. Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group

    Ophthalmology